Total medical devices industry venture financing deals in March 2019 worth $456.86m were announced globally, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 6.5% over the previous month and a drop of 39.3% when compared with the last 12-month average, which stood at $753.13m.
Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $279.63m. At the country level, the US topped the list in terms of deal value at $268.31m.
In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Europe and then Asia-Pacific.
The top country in terms of venture financing deals activity in March 2019 was the US with 45 deals, followed by Israel with three and the UK with three.
In 2019, as of the end of March 2019, medical devices venture financing deals worth $2.06bn were announced globally, marking a decrease of 22.8% year on year.
Medical devices industry venture financing deals in March 2019: Top deals
The top five medical devices industry venture financing deals accounted for 43.4% of the overall value during March 2019.
The combined value of the top five medical devices industry venture financing deals stood at $198.3m, against the overall value of $456.86m recorded for the month. The top announced medical devices industry venture financing deal tracked by GlobalData in March 2019 was Cambridge Innovation Capital, IP Group, Johnson & Johnson Innovation – JJDC, RT Ventures and Woodford Patient Capital Trust’s $52.6m venture financing of Inivata.
In second place was the $50m venture financing of SNIPR Biome by Life Sciences Partners, The Lundbeck Foundation, NORTHEAST FAMILY OFFICE and Wellington Partners Venture Capital and in third place was Berwind Private Equity, Fisk Ventures, Life Sciences Greenhouse of Central Pennsylvania, Roche Venture Fund and Vivo Capital’s $38.7m venture financing of Maculogix.
The $35m venture financing of Theranica Bio-Electronics by aMoon Partners, Corundum Open Innovation, Lightspeed Management Company, LionBird (Ventures) and Takoa Invest and OCV Partners, Ortho Vision and Secocha Ventures‘ venture financing of Ossio for $22m held fourth and fifth positions, respectively.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.